ID: ALA4762659

Max Phase: Preclinical

Molecular Formula: C16H14O4

Molecular Weight: 270.28

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1cc(C)c2c(=O)c3ccccc3oc2c1OC

Standard InChI:  InChI=1S/C16H14O4/c1-9-8-12(18-2)15(19-3)16-13(9)14(17)10-6-4-5-7-11(10)20-16/h4-8H,1-3H3

Standard InChI Key:  VVYFFOZHZYSYDQ-UHFFFAOYSA-N

Associated Targets(Human)

Tyrosinase 717 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 270.28Molecular Weight (Monoisotopic): 270.0892AlogP: 3.27#Rotatable Bonds: 2
Polar Surface Area: 48.67Molecular Species: NEUTRALHBA: 4HBD: 0
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 3.16CX LogD: 3.16
Aromatic Rings: 3Heavy Atoms: 20QED Weighted: 0.67Np Likeness Score: 0.67

References

1. Rosa GP,Palmeira A,Resende DISP,Almeida IF,Kane-Pagès A,Barreto MC,Sousa E,Pinto MMM.  (2021)  Xanthones for melanogenesis inhibition: Molecular docking and QSAR studies to understand their anti-tyrosinase activity.,  29  [PMID:33242700] [10.1016/j.bmc.2020.115873]

Source